Oral Care


Leadership
CHAIR
Cherry L. Estilo, DDS
USA
  VICE-CHAIR
Suzanne Carlisle, DDS
Canada
  VICE-CHAIR
Noam Yarom, DMD
Israel
  RESEARCH LEAD
Kıvanç Bektaş Kayhan, DDS, PhD
Turkey
  SYSTEMATIC REVIEW LEAD
Derek K. Smith, DDS, PhD
Israel

 

>> How to Join
To join a Study Group, login to your account, and click the Manage My Account/Profile.  Scroll down to your profile data and select "Edit". Then select the study group as one of your three Study Group selections. Click SAVE.

To join a Subgroup, you must be a member of the parent Study Group. Login to your account, and click Manage My Account/Profile.  Scroll down to your profile data and select "Edit". Then select the subgroup. Click SAVE.
Subgroups do not count toward your three Study Group selections.
>> More information or to contact Study Group/Subgroup leadership
To contact a Study Group or Subgroup Leader, search for their name in the member directory.
For more information or questions, contact the MASCC office at [email protected].

Mission and Goals

The Oral Care Study Group’s major goals are to enhance knowledge of the wide range of oral complications associated with cancer therapies and to support the translation into improved clinical management for patients. The group’s objectives are to understand the clinical impact of the wide variety of oral complications. These include xerostomia, dysgeusia, dysphagia, oral pain, fungal infection, viral infection, osteoradionecrosis, osteonecrosis from bisphosphonates, dental disease and trismus.

The Study Group aims to develop and coordinate new evidence-based management guidelines. In addition, the Oral Care Study Group serves as a resource for collaborative research efforts among members of this group as well as other members of MASCC and ISOO. Another focus of the Oral Care Study Group is education for members of MASCC and ISOO. The group will undertake multiple, systematic reviews of the incidence and prevalence or oral complications of cancer therapy, as well as their management, effects on quality of life, and economic impact. Efforts are underway to establish a multicenter study of members of the Oral Care Study group to prospectively collect data on various outcomes related to oral complications of cancer therapy.


Past Workshops

Patient Education

Oral Care Education Materials  
Members of MASCC, the International Society of Oral Oncology (ISOO), and the Oral Care Study Group have created four multilingual Fact Sheets and an Oral and Nutritional Care Education Video Storyboard that provide instructions for patients undergoing chemotherapy or head-and-neck radiation therapy. These materials provide instructions on caring for the mouth during active chemotherapy, and on self-care before, during, and after head-and-neck radiation. The Fact Sheets, based on systematic reviews, guidelines, and up-to-date, evidenced-based recommendations, are available in 18 languages.


Study Group News

MASCC Study Group Chairs Leading Study on Oral Complications of Radiotherapy 
Dr. Michael Brennan and Dr. Raj Lalla are the Co-Principal Investigators of an NIH-funded study, Treatment Outcomes from Head and Neck Cancer Therapies. An award of $8 million was made, in 2012, to Carolinas HealthCare System (CHS) to conduct a multi-center study.

The research team is studying dental and oral medicine outcomes among patients who have received high-dose radiation to the head and neck region. These outcomes include a permanent decrease in saliva production (hyposalivation) and impaired healing of bone around the teeth (osteoradionecrosis), adverse effects with a major impact on quality of life and risk for further dental complications.

Dr. Brennan is the current President of the International Society of Oral Oncology and recently served as the Chair of the Oral Care Study Group of MASCC. Dr Lalla is the current Chair of the MASCC Mucositis Study Group and also is a MASCC Board Member.


Clinical Research Initiative

Diagnostic and Management Practices for Oral Chronic Graft-Versus-Host Disease (cGVHD)
The Oral Care Study Group conducted a study on the diagnosis and treatment of oral chronic graft-versus-host disease (cGVHD). The study was designed to assess common practices, as well as to determine use of the National Institute of Health scale for the diagnosis and grading of oral cGVHD. The project was headed by Sharon Elad, DMD, MSc, Eastman Institute for Oral Health, University of Rochester Medical Center.

A survey was distributed to Oral Care Study Group and MASCC/ISOO members in order to identify medical centers with experience in managing patients with oral cGVHD. The structured survey contained questions about the respondents’ demographics, whether or not they treat oral cGVHD, evaluation tools, diagnostic aids, topical treatments, and preventive measures. >> Read More


Recent Member Publications

Oral Care Study Group members have published widely in Supportive Care in Cancer and many other journals. See a selection of recent articles


Resources

Related Links

Mouth Cancer Foundation
National Cancer Institute information on Oral Mucositis